8-41738095-T-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000037.4(ANK1):​c.130-4026A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.558 in 152,032 control chromosomes in the GnomAD database, including 24,103 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.56 ( 24103 hom., cov: 32)

Consequence

ANK1
NM_000037.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.347

Publications

4 publications found
Variant links:
Genes affected
ANK1 (HGNC:492): (ankyrin 1) Ankyrins are a family of proteins that link the integral membrane proteins to the underlying spectrin-actin cytoskeleton and play key roles in activities such as cell motility, activation, proliferation, contact and the maintenance of specialized membrane domains. Multiple isoforms of ankyrin with different affinities for various target proteins are expressed in a tissue-specific, developmentally regulated manner. Most ankyrins are typically composed of three structural domains: an amino-terminal domain containing multiple ankyrin repeats; a central region with a highly conserved spectrin binding domain; and a carboxy-terminal regulatory domain which is the least conserved and subject to variation. Ankyrin 1, the prototype of this family, was first discovered in the erythrocytes, but since has also been found in brain and muscles. Mutations in erythrocytic ankyrin 1 have been associated in approximately half of all patients with hereditary spherocytosis. Complex patterns of alternative splicing in the regulatory domain, giving rise to different isoforms of ankyrin 1 have been described. Truncated muscle-specific isoforms of ankyrin 1 resulting from usage of an alternate promoter have also been identified. [provided by RefSeq, Dec 2008]
ANK1 Gene-Disease associations (from GenCC):
  • hereditary spherocytosis
    Inheritance: AR, AD Classification: DEFINITIVE, SUPPORTIVE, LIMITED Submitted by: ClinGen, Orphanet
  • hereditary spherocytosis type 1
    Inheritance: AR, AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Laboratory for Molecular Medicine

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.75 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000037.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ANK1
NM_000037.4
MANE Select
c.130-4026A>G
intron
N/ANP_000028.3
ANK1
NM_001142446.2
c.229-4026A>G
intron
N/ANP_001135918.1
ANK1
NM_020476.3
c.130-4026A>G
intron
N/ANP_065209.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ANK1
ENST00000289734.13
TSL:1 MANE Select
c.130-4026A>G
intron
N/AENSP00000289734.8
ANK1
ENST00000265709.14
TSL:1
c.229-4026A>G
intron
N/AENSP00000265709.8
ANK1
ENST00000347528.8
TSL:1
c.130-4026A>G
intron
N/AENSP00000339620.4

Frequencies

GnomAD3 genomes
AF:
0.558
AC:
84752
AN:
151914
Hom.:
24083
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.459
Gnomad AMI
AF:
0.617
Gnomad AMR
AF:
0.566
Gnomad ASJ
AF:
0.540
Gnomad EAS
AF:
0.770
Gnomad SAS
AF:
0.550
Gnomad FIN
AF:
0.537
Gnomad MID
AF:
0.566
Gnomad NFE
AF:
0.604
Gnomad OTH
AF:
0.555
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.558
AC:
84809
AN:
152032
Hom.:
24103
Cov.:
32
AF XY:
0.557
AC XY:
41364
AN XY:
74318
show subpopulations
African (AFR)
AF:
0.459
AC:
19030
AN:
41416
American (AMR)
AF:
0.566
AC:
8649
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.540
AC:
1872
AN:
3468
East Asian (EAS)
AF:
0.770
AC:
3980
AN:
5172
South Asian (SAS)
AF:
0.552
AC:
2658
AN:
4814
European-Finnish (FIN)
AF:
0.537
AC:
5676
AN:
10566
Middle Eastern (MID)
AF:
0.565
AC:
166
AN:
294
European-Non Finnish (NFE)
AF:
0.604
AC:
41044
AN:
67996
Other (OTH)
AF:
0.553
AC:
1171
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1883
3766
5648
7531
9414
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
734
1468
2202
2936
3670
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.590
Hom.:
44096
Bravo
AF:
0.557
Asia WGS
AF:
0.610
AC:
2120
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
6.0
DANN
Benign
0.75
PhyloP100
0.35
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs516606; hg19: chr8-41595613; API